{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:28:07Z","timestamp":1790504887905,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.neurol.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T16:42:57Z","timestamp":1469810577000},"page":"524-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Movement disorders in mitochondrial diseases"],"prefix":"10.1016","volume":"172","author":[{"given":"C.","family":"Tranchant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Anheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2016.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(11)61305-6","article-title":"Mitochondrial diseases","volume":"379","author":"Schapira","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.neurol.2016.07.003_bib0010","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1474-4422(10)70116-2","article-title":"A neurological perspective on mitochondrial disease","volume":"9","author":"McFarland","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2016.07.003_bib0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbabio.2009.09.005","article-title":"Mitochondrial DNA mutations and human disease","volume":"1797","author":"Tuppen","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"6255","key":"10.1016\/j.neurol.2016.07.003_bib0020","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.aac7516","article-title":"Mutations causing mitochondrial disease: what is new and what challenges remain?","volume":"349","author":"Lightowlers","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0035-3787(07)90400-2","article-title":"Approche diagnostique des maladies mitochondriales \u00e0 presentation neurologique","volume":"163","author":"Aur\u00e9","year":"2007","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2016.07.003_bib0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S0317167100008027","article-title":"Mitochondrial ataxias","volume":"36","author":"Finsterer","year":"2009","journal-title":"Can J Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.003_bib0035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMra1006610","article-title":"The autosomal recessive cerebellar ataxias","volume":"366","author":"Anheim","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2016.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/brain\/awl088","article-title":"Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene","volume":"129","author":"Horvath","year":"2006","journal-title":"Brain"},{"issue":"Spec No 2","key":"10.1016\/j.neurol.2016.07.003_bib0045","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1093\/hmg\/ddl233","article-title":"Mitochondrial DNA polymerase-gamma and human disease","volume":"15","author":"Hudson","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2016.07.003_bib0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mus.880170507","article-title":"Sensory neuropathy in infantile onset spinocerebellar ataxia (IOSCA)","volume":"17","author":"Koskinen","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2016.07.003_bib0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pediatrneurol.2011.12.006","article-title":"Identification of a novel Twinkle mutation in a family with infantile onset spinocerebellar ataxia by whole exome sequencing","volume":"46","author":"Dundar","year":"2012","journal-title":"Pediatr Neurol"},{"issue":"23","key":"10.1016\/j.neurol.2016.07.003_bib0060","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1212\/WNL.0b013e31821e558b","article-title":"RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions","volume":"76","author":"Fratter","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/brain\/awm272","article-title":"Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance","volume":"131","author":"Hudson","year":"2008","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neurol.2016.07.003_bib0070","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archneurol.2012.206","article-title":"Heterogeneity of coenzyme Q10 deficiency: patient study and literature review","volume":"69","author":"Emmanuele","year":"2012","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.003_bib0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajhg.2007.12.024","article-title":"ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency","volume":"82","author":"Lagier-Tourenne","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2016.07.003_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1750-1172-8-173","article-title":"Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression","volume":"8","author":"Mignot","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.003_bib0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurol.2014.03.008","article-title":"Pathophysiogical and therapeutic progress in Friedreich ataxia","volume":"170","author":"Puccio","year":"2014","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.003_bib0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mds.26382","article-title":"Delayed-onset Friedreich's ataxia revisited","volume":"31","author":"Lecocq","year":"2016","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.003_bib0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ng.544","article-title":"Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28","volume":"42","author":"Di Bella","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/MCB.01470-06","article-title":"Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia","volume":"27","author":"Koppen","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.003_bib0105","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.neurol.2016.07.003_bib0110","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.0000000000001369","article-title":"SPG7 mutations are a common cause of undiagnosed ataxia","volume":"84","author":"Pfeffer","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.003_bib0115","doi-asserted-by":"crossref","first-page":"e1002325","DOI":"10.1371\/journal.pgen.1002325","article-title":"Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases","author":"Pierson","year":"2011","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/72769","article-title":"ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF","volume":"24","author":"Engert","year":"2000","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.003_bib0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.24509","article-title":"New practical definitions for the diagnosis of autosomal recessive spastic ataxia of Charlevoix\u2013Saguenay","volume":"78","author":"Pilliod","year":"2015","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2016.07.003_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1172-8-41","article-title":"Autosomal recessive spastic ataxia of Charlevoix\u2013Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum","volume":"15","author":"Synofzik","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjophthalmol-2012-302309","article-title":"Retinal nerve fibre layer thickness in ARSACS: myelination or hypertrophy?","volume":"97","author":"Garcia-Martin","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.neurol.2016.07.003_bib0140","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3174\/ajnr.A0603","article-title":"Autosomal recessive spastic ataxia of Charlevoix-Saguenay: a report of MR imaging in 5 patients","volume":"28","author":"Martin","year":"2007","journal-title":"AJNR"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.003_bib0145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/brain\/112.5.1231","article-title":"Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study","volume":"112","author":"Berkovic","year":"1989","journal-title":"Brain"},{"issue":"22","key":"10.1016\/j.neurol.2016.07.003_bib0150","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0b013e318294b44c","article-title":"Phenotypic heterogeneity of the 8344A>G mtDNA \u201cMERRF\u201d mutation","volume":"80","author":"Mancuso","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.003_bib0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/088307389400900102","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts","volume":"9","author":"Hirano","year":"1994","journal-title":"J Child Neurol"},{"issue":"Suppl. 4","key":"10.1016\/j.neurol.2016.07.003_bib0160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1528-1167.2012.03618.x","article-title":"Mitochondrial diseases and epilepsy","volume":"53","author":"Bindoff","year":"2012","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.003_bib0165","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/01.wnl.0000295505.74234.d0","article-title":"Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonus","volume":"70","author":"La Morgia","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.003_bib0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jnnp.2008.157354","article-title":"Progressive myoclonic epilepsy as an adult-onset manifestation of Leigh syndrome due to m.14487T>C.J","volume":"81","author":"Dermaut","year":"2010","journal-title":"Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.003_bib0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jmg.39.3.162","article-title":"Leber hereditary optic neuropathy","volume":"39","author":"Man","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2016.07.003_bib0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.59.2.160","article-title":"Leber's \u201cplus\u201d: neurological abnormalities in patients with Leber's hereditary optic neuropathy","volume":"59","author":"Nikoskelainen","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.003_bib0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10072-012-1013-1","article-title":"A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation","volume":"34","author":"Saracchi","year":"2013","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh Syndrome: one disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.003_bib0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jnnp-2012-304426","article-title":"A guide to diagnosis and treatment of Leigh syndrome","volume":"85","author":"Baertling","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.003_bib0200","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/1817-1745.165683","article-title":"A case of mitochondrial cytopathy with exertion induced dystonia","volume":"10","author":"Chandra","year":"2015","journal-title":"J Pediatr Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2016.07.003_bib0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/hmg\/ddg026","article-title":"An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria","volume":"12","author":"H\u00f6rtnagel","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.003_bib0210","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","article-title":"Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation","volume":"89","author":"Hartig","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.003_bib0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa020817","article-title":"Genetic, clinical, and radiographic delineation of Hallervorden\u2013Spatz syndrome","volume":"348","author":"Hayflick","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.003_bib0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.10650","article-title":"Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden\u2013Spatz syndrome) and pantothenate kinase-associated neurodegeneration","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2016.07.003_bib0225","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/brain\/awt095","article-title":"\u03b2-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation","volume":"136","author":"Hayflick","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/hmg\/ddr458","article-title":"Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology","volume":"21","author":"Engl","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.003_bib0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neurol.2013.06.003","article-title":"Mitochondrial dysfunctions in Parkinson's disease","volume":"170","author":"Gautier","year":"2014","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.003_bib0240","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.23651","article-title":"Parkinson's syndrome and Parkinson's disease in mitochondrial disorders","volume":"26","author":"Finsterer","year":"2011","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.003_bib0245","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1034\/j.1600-0404.2002.01221.x","article-title":"Parkinson syndrome as a manifestation of mitochondriopathy","volume":"105","author":"Finsterer","year":"2002","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.003_bib0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000250334.48038.7a","article-title":"Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys","volume":"68","author":"Horvath","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2016.07.003_bib0255","first-page":"595","article-title":"Leber \u201cplus\u201d disease: optic neuropathy, parkinsonian syndrome and supranuclear ophthalmoplegia","volume":"153","author":"Thobois","year":"1997","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"10.1016\/j.neurol.2016.07.003_bib0260","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z","article-title":"A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism\/MELAS overlap syndrome","volume":"45","author":"De Coo","year":"1999","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2016.07.003_bib0265","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ana.20831","article-title":"Early-onset familial parkinsonism due to POLG mutations","volume":"59","author":"Davidzon","year":"2006","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/WNL.0b013e31829a3438","article-title":"Extensive intracranial calcifications in a patient with a novel polymerase \u03b3-1 mutation","volume":"81","author":"Sidiropoulos","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2016.07.003_bib0275","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/mds.22198","article-title":"Neurodegenerative parkinsonism and progressive external ophthalmoplegia with a Twinkle mutation","volume":"24","author":"Vandenberghe","year":"2009","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.neurol.2016.07.003_bib0280","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archneur.64.7.998","article-title":"Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle","volume":"64","author":"Baloh","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2016.07.003_bib0285","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.410380321","article-title":"A novel mitochondrial ATPase 6 point mutation infamilial bilateral striatal necrosis","volume":"38","author":"Thyagarajan","year":"1995","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2016.07.003_bib0290","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mds.20363","article-title":"Adult-onset chorea and mitochondrial cytopathy","volume":"20","author":"Caer","year":"2005","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2016.07.003_bib0295","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ymgme.2007.06.001","article-title":"HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids","volume":"92","author":"Yang","year":"2007","journal-title":"Mol Genet Metab"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871630025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871630025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T01:21:39Z","timestamp":1536542499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537871630025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":59,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S003537871630025X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.07.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Movement disorders in mitochondrial diseases","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}